Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Versus Solifenacin Versus Their Combination for Improving Double-J Ureteral Stent-Related Symptoms
NCT07617922Phase 2Recruiting
- Sponsor
- Beni Suef University
- Start
- May 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in ureteral stent-related symptoms (USRS) comparing Solifenacin, Melatonin and Solifenacin Plus Melatonin (3 arms). Primary endpoint: Total Ureteral Stent Symptom Questionnaire at 7 days. Started May 2026; status: recruiting.
02
Drugs
melatoninsolifenacin
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT07617922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07617922.